Sensus Healthcare (SRTS) to Release Earnings on Thursday

Sensus Healthcare (NASDAQ:SRTS) will be releasing its earnings data after the market closes on Thursday, May 9th. Analysts expect Sensus Healthcare to post earnings of ($0.04) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.14. The business had revenue of $12.57 million for the quarter, compared to analysts’ expectations of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a return on equity of 1.04%.

Sensus Healthcare Stock Down 4.0 %

NASDAQ:SRTS opened at $3.61 on Thursday. The stock has a market cap of $59.17 million, a P/E ratio of 120.37 and a beta of 0.91. The firm’s fifty day simple moving average is $3.72 and its 200 day simple moving average is $3.07. Sensus Healthcare has a twelve month low of $1.79 and a twelve month high of $5.38.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.